The three types of DMARDs are biologic, conventional, and targeted synthetic DMARDs. These all have the aim of slowing down PsA to save the joints. They do it by reducing inflammation and ...

However, there is a risk of infection associated with synthetic mesh materials, and the mesh can erode into the bowel. In the 1990s, a new class of biologic mesh materials was introduced.

The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) than in patients who ...

Biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) seemed to be the most effective treatments for patients with acute psoriatic arthritis (PsA) dactylitis. In a ...

Results from this cohort study showed that biologics were much more effective than conventional synthetic drugs as primary therapy. Patients with adult-onset Still's disease were much more likely ...

Bionic Biologics represent a novel therapeutic modality that integrates principles of biologic and synthetic design. This innovative platform enables the targeting of well-validated yet previously ...

Please provide your email address to receive an email when new articles are posted on . Demographic factors were significantly associated with slower or faster initiation of b/ts DMARDs for RA.

However, there is a risk of infection associated with synthetic mesh materials, and the mesh can erode into the bowel. In the 1990s, a new class of biologic mesh materials was introduced.